Atai Life Sciences N.V. (ETR:9VC)
Germany
· Delayed Price · Currency is EUR 1.277
-0.038 (-2.85%)
At close: Apr 25, 2025, 5:30 PM CET
Atai Life Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | -149.27 | -40.22 | -152.39 | -167.81 | -169.84 | Upgrade
|
| Depreciation & Amortization | 0.47 | 0.32 | 0.17 | 0.05 | 0.02 | Upgrade
|
| Other Amortization | 0.52 | 0.37 | 0.13 | 0.2 | 0.06 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.17 | -0.06 | -1.48 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.92 | - | 0.36 | 15.48 | 12.02 | Upgrade
|
| Loss (Gain) From Sale of Investments | 2.08 | 1.01 | - | -4.58 | -19.86 | Upgrade
|
| Loss (Gain) on Equity Investments | 2 | 3.59 | 16.01 | 58.56 | 76.51 | Upgrade
|
| Stock-Based Compensation | 25.49 | 32.98 | 42.38 | 63.36 | 67.16 | Upgrade
|
| Other Operating Activities | 45.73 | -89.58 | -6.3 | -20.9 | 8.71 | Upgrade
|
| Change in Accounts Payable | -1.87 | 2.14 | -3.03 | 2.3 | 1.7 | Upgrade
|
| Change in Unearned Revenue | - | - | - | 0.01 | - | Upgrade
|
| Change in Other Net Operating Assets | -7.33 | 5.33 | -0.3 | -9.92 | 2.75 | Upgrade
|
| Operating Cash Flow | -82.44 | -84.12 | -104.47 | -63.25 | -20.77 | Upgrade
|
| Capital Expenditures | -0.01 | -0.26 | -0.77 | -1.17 | -0.06 | Upgrade
|
| Cash Acquisitions | 0.36 | - | - | - | - | Upgrade
|
| Divestitures | - | -0.44 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.09 | -0.33 | -0.25 | -0.96 | - | Upgrade
|
| Investment in Securities | 66.65 | -46.75 | -82.82 | -76.6 | -26.01 | Upgrade
|
| Other Investing Activities | -7.75 | -5.51 | -3 | -2.55 | -2.2 | Upgrade
|
| Investing Cash Flow | 59.17 | -53.3 | -86.85 | -81.28 | -28.27 | Upgrade
|
| Long-Term Debt Issued | 5 | - | 15 | 4.01 | 32.5 | Upgrade
|
| Net Debt Issued (Repaid) | 5 | - | 15 | 4.01 | 32.5 | Upgrade
|
| Issuance of Common Stock | 0.54 | 0.23 | 6.93 | 418.21 | 82.56 | Upgrade
|
| Other Financing Activities | -0.16 | -8.58 | -1.15 | -12.35 | -2.01 | Upgrade
|
| Financing Cash Flow | 5.37 | -8.36 | 20.79 | 409.86 | 113.05 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.36 | 0.19 | -1.12 | -0.32 | 3.17 | Upgrade
|
| Net Cash Flow | -17.53 | -145.58 | -171.65 | 265.02 | 67.18 | Upgrade
|
| Free Cash Flow | -82.44 | -84.38 | -105.24 | -64.42 | -20.83 | Upgrade
|
| Free Cash Flow Margin | -26767.21% | -26871.66% | -45167.38% | -316.15% | - | Upgrade
|
| Free Cash Flow Per Share | -0.52 | -0.53 | -0.68 | -0.47 | -0.22 | Upgrade
|
| Cash Interest Paid | 2.16 | 1.92 | 0.51 | - | - | Upgrade
|
| Cash Income Tax Paid | 0.41 | 1.48 | 0.65 | - | - | Upgrade
|
| Levered Free Cash Flow | -54.12 | -37.17 | -51.63 | -15.6 | -34.43 | Upgrade
|
| Unlevered Free Cash Flow | -52.68 | -35.88 | -51.19 | -15.8 | -34.49 | Upgrade
|
| Change in Net Working Capital | 16.2 | -7.83 | 2.44 | 1.88 | -17.47 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.